Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Heart Tronics Inc. (HRTT : OTC)

• Company Description    Heart Tronics Inc, formerly Signalife Inc., is a medical device company engaged in the research, development and marketing of medical devices that monitor and measure physiological signals, intended to detect diseases that affect an individual's health. The Company is dedicated to creating the next-generation of heart monitoring technology. Heart Tronics's unique patented technology reduces distortions, allowing physicians and cardiologists to monitor ECG signals from a patient in his or her everyday environment, solving a major cardiac care problem and giving researchers access to new and relevant clinical data. The Company's initial product, the Signalife Fidelity 100 Monitor System or (Fidelity 100), is a heart monitoring system that uses Signalife's own signal acquisition technology to obtain, amplify and process physiological signals associated with a patient's cardiovascular system. The Company also has several products in the development stage that operate using the same signal acquisition technology. Number of Employees:

• Price / Volume Information    Yesterday's Closing Price: $0.00 Daily Weekly Monthly 20 Day Moving Average: 0 shares Shares Outstanding: (millions) Market Capitalization: $ (millions) Beta: 895.57 52 Week High: $0.00 52 Week Low: $0.00 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 0.00% 12.62% 12 Week 0.00% 9.93% Year To Date % %

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 4705 LAUREL CANYON BLVD SUITE 203 - STUDIO CITY,CA 91607 USA ph: 864-233-2300 fax: 818-432-4567 None http://www.hearttronics.com

• General Corporate Information    Officers Lowell T. Harmison - President; Chief Executive Officer and Director Kevin F. Pickard - Interim Chief Financial Officer Jennifer Black - Director Rowland Perkins - Director Charles H. Harrison - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 42234M101 SIC: 3845 Fiscal Year Fiscal Year End: December Last Reported Quarter: - Next Expected EPS Date: - Share - Related Items Shares Outstanding: Most Recent Split Date: 9.00 (0.00:1) Beta: 895.57 Market Capitalization: $ (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: -

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 03/31/22 - - 12/31/21 - - 09/30/21 - - ROA 03/31/22 - - 12/31/21 - - 09/30/21 - - Current Ratio 03/31/22 - - 12/31/21 - - 09/30/21 - - Quick Ratio 03/31/22 - - 12/31/21 - - 09/30/21 - - Operating Margin 03/31/22 - - 12/31/21 - - 09/30/21 - - Net Margin 03/31/22 - - 12/31/21 - - 09/30/21 - - Pre-Tax Margin 03/31/22 - - 12/31/21 - - 09/30/21 - - Book Value 03/31/22 - - 12/31/21 - - 09/30/21 - - Inventory Turnover 03/31/22 - - 12/31/21 - - 09/30/21 - - Debt-to-Equity 03/31/22 - - 12/31/21 - - 09/30/21 - - Debt-to-Capital 03/31/22 - - 12/31/21 - - 09/30/21 - -

Powered by Zacks Investment Research ©